Report Detail
Global mRNA Delivery System Market 2026 by Company, Regions, Type and Application, Forecast to 2032
- RnM4719111 |
- 29 June, 2026 |
- Global |
- 92 Pages |
- GIR |
- Other
According to our (Global Info Research) latest study, the global mRNA Delivery System market size was valued at US$ 1039 million in 2025 and is forecast to a readjusted size of US$ 1622 million by 2032 with a CAGR of 6.7% during review period.
mRNA has a large molecular weight and strong hydrophilicity, but its single stranded structure makes it extremely unstable and easily degraded. It carries a negative charge and is difficult to deliver through cell membranes with negative charges on the surface. Therefore, special modification or encapsulation delivery systems are required to achieve intracellular expression of mRNA. Delivery technology is the core patented technology of mRNA companies. Lipid nanoparticles (LNP) are currently the mainstream delivery carrier method. Due to its easy absorption by antigen-presenting cells, it is most commonly used in vaccines, and currently the three major mRNA vaccine giants have adopted LNP delivery technology. In addition, there are cationic lipid complexes (LPX), lipid polymer complexes (LPP) Polymer nanoparticles (PNP), inorganic nanoparticles (INP), cationic nanoemulsions (CNE), as well as the GalNac N-acetylgalactosamine technology independently developed by Ruibo Biotechnology, can be used for targeted delivery to the liver.
This report is a detailed and comprehensive analysis for global mRNA Delivery System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global mRNA Delivery System market size and forecasts, in consumption value ($ Million), 2021-2032
Global mRNA Delivery System market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global mRNA Delivery System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global mRNA Delivery System market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for mRNA Delivery System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global mRNA Delivery System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Moderna, Genevant, Arbutus, Evonik Industries, Suzhou Abogen Biosciences, AIM Vaccine, InnoRNA, Jiachen Xihai(Hangzhou)Biotechnology, Longuide Biopharma Corporation, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
mRNA Delivery System market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
LNP Delivery
PNP Delivery
Others
Market segment by Application
Vaccine Development
Gene Therapy
Protein Replacement Therapy
Others
Market segment by players, this report covers
Moderna
Genevant
Arbutus
Evonik Industries
Suzhou Abogen Biosciences
AIM Vaccine
InnoRNA
Jiachen Xihai(Hangzhou)Biotechnology
Longuide Biopharma Corporation
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe mRNA Delivery System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of mRNA Delivery System, with revenue, gross margin, and global market share of mRNA Delivery System from 2021 to 2026.
Chapter 3, the mRNA Delivery System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and mRNA Delivery System market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of mRNA Delivery System.
Chapter 13, to describe mRNA Delivery System research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of mRNA Delivery System by Type
- 1.3.1 Overview: Global mRNA Delivery System Market Size by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 Global mRNA Delivery System Consumption Value Market Share by Type in 2025
- 1.3.3 LNP Delivery
- 1.3.4 PNP Delivery
- 1.3.5 Others
- 1.4 Global mRNA Delivery System Market by Application
- 1.4.1 Overview: Global mRNA Delivery System Market Size by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Vaccine Development
- 1.4.3 Gene Therapy
- 1.4.4 Protein Replacement Therapy
- 1.4.5 Others
- 1.5 Global mRNA Delivery System Market Size & Forecast
- 1.6 Global mRNA Delivery System Market Size and Forecast by Region
- 1.6.1 Global mRNA Delivery System Market Size by Region: 2021 VS 2025 VS 2032
- 1.6.2 Global mRNA Delivery System Market Size by Region, (2021-2032)
- 1.6.3 North America mRNA Delivery System Market Size and Prospect (2021-2032)
- 1.6.4 Europe mRNA Delivery System Market Size and Prospect (2021-2032)
- 1.6.5 Asia-Pacific mRNA Delivery System Market Size and Prospect (2021-2032)
- 1.6.6 South America mRNA Delivery System Market Size and Prospect (2021-2032)
- 1.6.7 Middle East & Africa mRNA Delivery System Market Size and Prospect (2021-2032)
2 Company Profiles
- 2.1 Moderna
- 2.1.1 Moderna Details
- 2.1.2 Moderna Major Business
- 2.1.3 Moderna mRNA Delivery System Product and Solutions
- 2.1.4 Moderna mRNA Delivery System Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Moderna Recent Developments and Future Plans
- 2.2 Genevant
- 2.2.1 Genevant Details
- 2.2.2 Genevant Major Business
- 2.2.3 Genevant mRNA Delivery System Product and Solutions
- 2.2.4 Genevant mRNA Delivery System Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Genevant Recent Developments and Future Plans
- 2.3 Arbutus
- 2.3.1 Arbutus Details
- 2.3.2 Arbutus Major Business
- 2.3.3 Arbutus mRNA Delivery System Product and Solutions
- 2.3.4 Arbutus mRNA Delivery System Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Arbutus Recent Developments and Future Plans
- 2.4 Evonik Industries
- 2.4.1 Evonik Industries Details
- 2.4.2 Evonik Industries Major Business
- 2.4.3 Evonik Industries mRNA Delivery System Product and Solutions
- 2.4.4 Evonik Industries mRNA Delivery System Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Evonik Industries Recent Developments and Future Plans
- 2.5 Suzhou Abogen Biosciences
- 2.5.1 Suzhou Abogen Biosciences Details
- 2.5.2 Suzhou Abogen Biosciences Major Business
- 2.5.3 Suzhou Abogen Biosciences mRNA Delivery System Product and Solutions
- 2.5.4 Suzhou Abogen Biosciences mRNA Delivery System Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Suzhou Abogen Biosciences Recent Developments and Future Plans
- 2.6 AIM Vaccine
- 2.6.1 AIM Vaccine Details
- 2.6.2 AIM Vaccine Major Business
- 2.6.3 AIM Vaccine mRNA Delivery System Product and Solutions
- 2.6.4 AIM Vaccine mRNA Delivery System Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 AIM Vaccine Recent Developments and Future Plans
- 2.7 InnoRNA
- 2.7.1 InnoRNA Details
- 2.7.2 InnoRNA Major Business
- 2.7.3 InnoRNA mRNA Delivery System Product and Solutions
- 2.7.4 InnoRNA mRNA Delivery System Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 InnoRNA Recent Developments and Future Plans
- 2.8 Jiachen Xihai(Hangzhou)Biotechnology
- 2.8.1 Jiachen Xihai(Hangzhou)Biotechnology Details
- 2.8.2 Jiachen Xihai(Hangzhou)Biotechnology Major Business
- 2.8.3 Jiachen Xihai(Hangzhou)Biotechnology mRNA Delivery System Product and Solutions
- 2.8.4 Jiachen Xihai(Hangzhou)Biotechnology mRNA Delivery System Revenue, Gross Margin and Market Share (2021-2026)
- 2.8.5 Jiachen Xihai(Hangzhou)Biotechnology Recent Developments and Future Plans
- 2.9 Longuide Biopharma Corporation
- 2.9.1 Longuide Biopharma Corporation Details
- 2.9.2 Longuide Biopharma Corporation Major Business
- 2.9.3 Longuide Biopharma Corporation mRNA Delivery System Product and Solutions
- 2.9.4 Longuide Biopharma Corporation mRNA Delivery System Revenue, Gross Margin and Market Share (2021-2026)
- 2.9.5 Longuide Biopharma Corporation Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global mRNA Delivery System Revenue and Share by Players (2021-2026)
- 3.2 Market Share Analysis (2025)
- 3.2.1 Market Share of mRNA Delivery System by Company Revenue
- 3.2.2 Top 3 mRNA Delivery System Players Market Share in 2025
- 3.2.3 Top 6 mRNA Delivery System Players Market Share in 2025
- 3.3 mRNA Delivery System Market: Overall Company Footprint Analysis
- 3.3.1 mRNA Delivery System Market: Region Footprint
- 3.3.2 mRNA Delivery System Market: Company Product Type Footprint
- 3.3.3 mRNA Delivery System Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global mRNA Delivery System Consumption Value and Market Share by Type (2021-2026)
- 4.2 Global mRNA Delivery System Market Forecast by Type (2027-2032)
5 Market Size Segment by Application
- 5.1 Global mRNA Delivery System Consumption Value Market Share by Application (2021-2026)
- 5.2 Global mRNA Delivery System Market Forecast by Application (2027-2032)
6 North America
- 6.1 North America mRNA Delivery System Consumption Value by Type (2021-2032)
- 6.2 North America mRNA Delivery System Market Size by Application (2021-2032)
- 6.3 North America mRNA Delivery System Market Size by Country
- 6.3.1 North America mRNA Delivery System Consumption Value by Country (2021-2032)
- 6.3.2 United States mRNA Delivery System Market Size and Forecast (2021-2032)
- 6.3.3 Canada mRNA Delivery System Market Size and Forecast (2021-2032)
- 6.3.4 Mexico mRNA Delivery System Market Size and Forecast (2021-2032)
7 Europe
- 7.1 Europe mRNA Delivery System Consumption Value by Type (2021-2032)
- 7.2 Europe mRNA Delivery System Consumption Value by Application (2021-2032)
- 7.3 Europe mRNA Delivery System Market Size by Country
- 7.3.1 Europe mRNA Delivery System Consumption Value by Country (2021-2032)
- 7.3.2 Germany mRNA Delivery System Market Size and Forecast (2021-2032)
- 7.3.3 France mRNA Delivery System Market Size and Forecast (2021-2032)
- 7.3.4 United Kingdom mRNA Delivery System Market Size and Forecast (2021-2032)
- 7.3.5 Russia mRNA Delivery System Market Size and Forecast (2021-2032)
- 7.3.6 Italy mRNA Delivery System Market Size and Forecast (2021-2032)
8 Asia-Pacific
- 8.1 Asia-Pacific mRNA Delivery System Consumption Value by Type (2021-2032)
- 8.2 Asia-Pacific mRNA Delivery System Consumption Value by Application (2021-2032)
- 8.3 Asia-Pacific mRNA Delivery System Market Size by Region
- 8.3.1 Asia-Pacific mRNA Delivery System Consumption Value by Region (2021-2032)
- 8.3.2 China mRNA Delivery System Market Size and Forecast (2021-2032)
- 8.3.3 Japan mRNA Delivery System Market Size and Forecast (2021-2032)
- 8.3.4 South Korea mRNA Delivery System Market Size and Forecast (2021-2032)
- 8.3.5 India mRNA Delivery System Market Size and Forecast (2021-2032)
- 8.3.6 Southeast Asia mRNA Delivery System Market Size and Forecast (2021-2032)
- 8.3.7 Australia mRNA Delivery System Market Size and Forecast (2021-2032)
9 South America
- 9.1 South America mRNA Delivery System Consumption Value by Type (2021-2032)
- 9.2 South America mRNA Delivery System Consumption Value by Application (2021-2032)
- 9.3 South America mRNA Delivery System Market Size by Country
- 9.3.1 South America mRNA Delivery System Consumption Value by Country (2021-2032)
- 9.3.2 Brazil mRNA Delivery System Market Size and Forecast (2021-2032)
- 9.3.3 Argentina mRNA Delivery System Market Size and Forecast (2021-2032)
10 Middle East & Africa
- 10.1 Middle East & Africa mRNA Delivery System Consumption Value by Type (2021-2032)
- 10.2 Middle East & Africa mRNA Delivery System Consumption Value by Application (2021-2032)
- 10.3 Middle East & Africa mRNA Delivery System Market Size by Country
- 10.3.1 Middle East & Africa mRNA Delivery System Consumption Value by Country (2021-2032)
- 10.3.2 Turkey mRNA Delivery System Market Size and Forecast (2021-2032)
- 10.3.3 Saudi Arabia mRNA Delivery System Market Size and Forecast (2021-2032)
- 10.3.4 UAE mRNA Delivery System Market Size and Forecast (2021-2032)
11 Market Dynamics
- 11.1 mRNA Delivery System Market Drivers
- 11.2 mRNA Delivery System Market Restraints
- 11.3 mRNA Delivery System Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 mRNA Delivery System Industry Chain
- 12.2 mRNA Delivery System Upstream Analysis
- 12.3 mRNA Delivery System Midstream Analysis
- 12.4 mRNA Delivery System Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on mRNA Delivery System. Industry analysis & Market Report on mRNA Delivery System is a syndicated market report, published as Global mRNA Delivery System Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of mRNA Delivery System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
